Search for: "Hospira Inc."
Results 101 - 120
of 287
Sorted by Relevance
|
Sort by Date
13 Nov 2013, 3:48 am
Some of the leading makers of generic drugs include Hospira Inc., HSP +0.55%Hospira Inc.U.S.: NYSE$38.74 +0.21+0.55% Nov. 12, 2013 4:00 pm Volume (Delayed 15m) : 2.36MAFTER HOURS$38.58 -0.16-0.43% Nov. 12, 2013... [read post]
9 Aug 2019, 8:54 am
Hospira, Inc. [read post]
4 Jun 2020, 2:58 am
Hospira, Inc. v. [read post]
30 Jul 2012, 1:13 pm
Hospira, Inc., 2012 U.S. [read post]
9 Aug 2016, 7:50 am
Hospira, Inc., 1-15-cv-00839 (DED August 5, 2016, Order) (Andrews, J.) [read post]
27 Jul 2015, 6:53 am
Hospira, Inc., 3-14-cv-01345 (CASD July 21, 2015, Order) (Huff, J.) [read post]
31 Jul 2023, 1:47 pm
” Hospira, Inc. v. [read post]
1 Sep 2021, 12:36 pm
Hospira, Inc. [read post]
13 Nov 2015, 1:40 pm
OEA, Inc., 270 F.3d 1353 (Fed. [read post]
10 Mar 2016, 6:01 am
Hospira, Inc. [read post]
17 Aug 2011, 3:52 pm
According to the Order, ALJ Rogers granted a joint motion filed by Complainant Eli Lilly and Company (“Lilly”) and Respondents Hospira, Inc. [read post]
7 Mar 2012, 9:15 am
The firm in 2011 advocated for health care industry members that included the Blue Cross and Blue Shield Association and pharmaceutical and medical device company Hospira Inc., according to congressional records. [read post]
21 Jan 2014, 9:23 am
Hospira, Inc., C.A. [read post]
28 Sep 2010, 9:53 am
Drug Manufacturer Hospira, Inc. is Out of Product Sodium Thiopental isn't made by many manufacturers -- in fact, there is only one company in the United States that makes the drug, Hospira Inc. of Lake Forest, Illinois. [read post]
28 Aug 2009, 8:11 am
Dayco Products LLC (trademark infringement) 9/4: Hospira Inc. and Orion Corporation v. [read post]
26 Sep 2014, 9:25 pm
Hospira, Inc., 675 F.3d 1324, 1335-36 (Fed. [read post]
10 Jul 2016, 10:00 pm
Hospira, Inc., the full Federal Circuit recently elaborated what exactly constitutes a "sale"for the purposes of the "on sale"bar under Pre-America Invents Act (AIA) 35 U.S.C. [read post]
25 Mar 2007, 9:19 pm
Following a successful patent defense on Zyprexa, Lilly now faces challenges to Gemzar (gemcitabine, an injectible chemotherapy that treats several forms of cancer) from Sicor Pharmaceuticals Inc., Mayne Pharma Inc. and Sun Pharmaceutical Industries Inc. through challenges mounted via provisions of the Hatch-Waxman Act. [read post]
29 Jan 2011, 9:16 am
A week ago, I asked what they were going to do now that Hospira will no longer make thiopental. [read post]
24 Jan 2011, 12:31 pm
., Ltd. of China (“Hansoh”), Intas Pharmaceuticals Ltd. of India (“Intas”), ChemWerth, Inc. of Woodbridge, Connecticut (“ChemWerth”), and Hospira, Inc. of Lake Forest, Illinois (“Hospira”) (collectively, the “Proposed Respondents”) unlawfully and without authorization import into the U.S., sell for importation, and/or sell within the U.S. after importation certain gemcitabine and products containing same… [read post]
